Immunohistochemical analysis showed that positive immunostaining of NLRP3 and its activation marker CASP1 was detectable as brown granules in the cytoplasm of hepatocytes in liver sections of all patients with HCV-related liver disease (Fig. 2). This evidence concerns the gene NLRP3 and liver disorder.